Cadence looks to raise $85 million

Cadence Pharmaceuticals Inc. (NASDAQ:CADX) proposed to raise $85 million in a follow-on underwritten by Deutsche Bank; Leerink; JMP Securities, Wedbush; and Canaccord. Last week, FDA approved Cadence'...